Advertisement
DBD vs MTC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBD is a StrongBuy and MTC is a Hold.
DBD in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for DBD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on DBD as a result. In 43 of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for DBD just turned positive on October 01, 2026. Looking at past instances where DBD's MACD turned positive, the stock continued to rise in 23 of 32 cases over the following month. The odds of a continued upward trend are 72%.
DBD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in 174 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
DBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for DBD entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. DBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.387) is normal, around the industry mean (-1.734). P/E Ratio (22.275) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.074) among similar stocks. P/S Ratio (0.606) is also within normal values, averaging (71.128).
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for MTC turns positive, indicating new upward trend
MTC saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 78 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for MTC just turned positive on October 19, 2026. Looking at past instances where MTC's MACD turned positive, the stock continued to rise in 43 of 46 cases over the following month. The odds of a continued upward trend are 90%.
The 50-day moving average for MTC moved above the 200-day moving average on October 15, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +14.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTC advanced for three days, in 212 of 241 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
The Aroon Indicator entered an Uptrend today. In 80 of 87 cases where MTC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The 10-day RSI Indicator for MTC moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 46 cases where MTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
MTC broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. MTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MTC's P/B Ratio (41.563) is very high in comparison to the industry average of (3.532). P/E Ratio (7.026) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.708) among similar stocks. MTC's P/S Ratio (200.000) is very high in comparison to the industry average of (16.763).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
MTC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 29 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 4 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DBD | MTC | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 79% | 3 days ago 88% |
| Declines ODDS (%) | 15 days ago 60% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DBD’s FA Score shows that 0 FA rating(s) are green while MTC’s FA Score has 2 green FA rating(s).
- DBD’s FA Score: 0 green, 5 red.
- MTC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DBD’s TA Score shows that 6 TA indicator(s) are bullish while MTC’s TA Score has 5 bullish TA indicator(s).
- DBD’s TA Score: 6 bullish, 3 bearish.
- MTC’s TA Score: 5 bullish, 4 bearish.
Price Growth
DBD (@Packaged Software) experienced а +4.04% price change this week, while MTC (@Investment Banks/Brokers) price change was +23.25% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.42%. For the same industry, the average monthly price growth was -3.95%, and the average quarterly price growth was +4.32%.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.09%. For the same industry, the average monthly price growth was -16.78%, and the average quarterly price growth was -13.10%.
Reported Earning Dates
DBD is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Packaged Software (-0.42% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Investment Banks/Brokers (-5.09% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
Advertisement
DBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.
| Ticker / NAME | Correlation To DBD | 1D Price Change % | ||
|---|---|---|---|---|
| DBD | 100% | +1.61% | ||
| GDRX - DBD | 49% Loosely correlated | +1.40% | ||
| RAMP - DBD | 47% Loosely correlated | +0.10% | ||
| BLZE - DBD | 43% Loosely correlated | -7.82% | ||
| EEFT - DBD | 42% Loosely correlated | +1.73% | ||
| PAYO - DBD | 41% Loosely correlated | +0.14% | ||
More | ||||